Article Details
Retrieved on: 2024-09-09 14:01:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
78), along with the use of adjunctive monoclonal antibodies and immunotherapies (HR, 1.00; 95% CI, 0.93–1.09; P = .83). “Historically, the benefit ...
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here